Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action-Reference-Cited by-同舟云学术

Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action

Published:2021-12 Issue:12 Volume:9 Page:e1763-e1769
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Alvar Jorge,den Boer Margriet,Dagne Daniel Argaw

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Global leishmaniasis surveillance, 2017–2018, and first report on five additional indicators;Wkly Epidemiol Rec,2020

2. “Kala-Azar is a dishonest disease”: community perspectives on access barriers to visceral leishmaniasis (Kala-Azar) diagnosis and care in Southern Gadarif, Sudan;Sunyoto;Am J Trop Med Hyg,2018

3. Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, northern Ethiopia: a qualitative study;Coulborn;PLoS Negl Trop Dis,2018

4. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS One,2012

5. Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey;Cloots;Lancet Glob Health,2020

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and facilitators of visceral leishmaniasis case management in the Amhara Region, Northwest Ethiopia: an exploratory qualitative study;BMC Public Health;2024-09-13

2. A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules;Exploration of Drug Science;2024-09-06

3. A case–control study on risk factors for visceral leishmaniasis in West Pokot County, Kenya;Tropical Medicine & International Health;2024-09-04

4. A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis;Molecular Therapy - Methods & Clinical Development;2024-09

5. Diagnostic effectiveness of urine and saliva samples for detection of visceral leishmaniasis using rK39-based immunochromatographic test, Northwest, Ethiopia;Discover Medicine;2024-08-09